Objective
The primary objective of the meta-trial is to investigate whether
inhaled nebulised UFH in hospitalised patients with COVID-19 who do not
require immediate invasive mechanical ventilation, significantly reduces
rates of intubation (or death, for patients who died before intubation)
at day 28, compared to standard care alone. Primary outcomes for
individual studies may be different clinical or biochemical endpoints
and are listed in the individual trial protocols.